These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
413 related items for PubMed ID: 30968958
1. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany. Houareau C, Offergeld R. Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958 [Abstract] [Full Text] [Related]
2. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing. van de Laar TJ, Hogema BM, Molenaar-de Backer MW, Marijt-van der Kreek T, Zaaijer HL. Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233 [Abstract] [Full Text] [Related]
3. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
4. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015). Fiedler SA, Oberle D, Chudy M, Scheiblauer H, Henseler O, Halbauer J, Heiden M, Funk M. Vox Sang; 2019 Jul; 114(5):443-450. PubMed ID: 31012114 [Abstract] [Full Text] [Related]
5. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? Niederhauser C, Mansouri Taleghani B, Graziani M, Stolz M, Tinguely C, Schneider P. Swiss Med Wkly; 2008 Mar 08; 138(9-10):134-41. PubMed ID: 18330733 [Abstract] [Full Text] [Related]
6. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP. Transfus Clin Biol; 2004 Feb 08; 11(1):26-32. PubMed ID: 14980546 [Abstract] [Full Text] [Related]
7. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods. Kuhns MC, Busch MP. Mol Diagn Ther; 2006 Feb 08; 10(2):77-91. PubMed ID: 16669606 [Abstract] [Full Text] [Related]
8. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group. Transfusion; 2004 Sep 08; 44(9):1332-9. PubMed ID: 15318857 [Abstract] [Full Text] [Related]
9. NAT for HBV and anti-HBc testing increase blood safety. Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, Weichert W, Hedges D, Seifried E. Transfusion; 2002 Jul 08; 42(7):869-75. PubMed ID: 12375659 [Abstract] [Full Text] [Related]
10. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection? Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL. Transfusion; 2018 Sep 08; 58(9):2166-2170. PubMed ID: 30144082 [Abstract] [Full Text] [Related]
11. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Transfusion; 2005 Aug 08; 45(8):1247-57. PubMed ID: 16078909 [Abstract] [Full Text] [Related]
12. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? Stramer SL, Notari EP, Krysztof DE, Dodd RY. Transfusion; 2013 Oct 08; 53(10 Pt 2):2449-58. PubMed ID: 23607261 [Abstract] [Full Text] [Related]
13. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country. van de Laar TJ, Marijt-van der Kreek T, Molenaar-de Backer MW, Hogema BM, Zaaijer HL. Transfusion; 2015 Jun 08; 55(6):1206-13. PubMed ID: 25494685 [Abstract] [Full Text] [Related]
14. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Blood Transfus; 2017 Jan 08; 15(1):6-12. PubMed ID: 27416568 [Abstract] [Full Text] [Related]
15. Detection of hepatitis B virus infection in German blood donors 2008-2015. Scheiblauer H, Heiden M, Funk M, Oberle D, Kreß J, Jork C, Chudy M. Vox Sang; 2020 Apr 08; 115(3):152-161. PubMed ID: 32023664 [Abstract] [Full Text] [Related]
16. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations. Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S. Transfusion; 2006 Dec 08; 46(12):2047-52. PubMed ID: 17176315 [Abstract] [Full Text] [Related]
17. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection. Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group. Transfusion; 2014 Aug 08; 54(8):2084-91. PubMed ID: 24650170 [Abstract] [Full Text] [Related]
18. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply. Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Transfusion; 2015 Apr 08; 55(4):890-7. PubMed ID: 25363504 [Abstract] [Full Text] [Related]
19. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors. Stolz M, Tinguely C, Fontana S, Niederhauser C. Transfusion; 2014 Nov 08; 54(11):2961-7. PubMed ID: 24805974 [Abstract] [Full Text] [Related]
20. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC. Transfusion; 2007 Oct 08; 47(10):1809-15. PubMed ID: 17880605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]